147 related articles for article (PubMed ID: 3089808)
21. Outcome of chenodeoxycholic acid (CDCA) treatment in 125 patients with radiolucent gallstones. Factors influencing efficacy, withdrawal, symptoms and side effects and post-dissolution recurrence.
Maton PN; Iser JH; Reuben A; Saxton HM; Murphy GM; Dowling RH
Medicine (Baltimore); 1982 Mar; 61(2):86-97. PubMed ID: 7062856
[TBL] [Abstract][Full Text] [Related]
22. Interaction of chenodeoxycholic acid and dietary cholesterol in the treatment of cholesterol gallstones.
Doty JE; DenBesten L; Roslyn JJ; Pitt HA; Kuchenbecker SL; Porter-Fink V
Am J Surg; 1982 Jan; 143(1):48-54. PubMed ID: 7053655
[TBL] [Abstract][Full Text] [Related]
23. Effect of varying doses of chenodeoxycholic acid on bile lipid and biliary bile acid composition in gallstone patients: a dose-response study.
Thistle JL; Hofmann AF; Yu PY; Ott B
Am J Dig Dis; 1977 Jan; 22(1):1-6. PubMed ID: 835542
[TBL] [Abstract][Full Text] [Related]
24. Differing effects of ursodeoxycholic or chenodeoxycholic acid on biliary cholesterol saturation and bile acid metabolism in man. A dose-response study.
Thistle JL; Larusso NF; Hofmann AF; Turcotte J; Carlson GL; Ott BJ
Dig Dis Sci; 1982 Feb; 27(2):161-8. PubMed ID: 7075411
[TBL] [Abstract][Full Text] [Related]
25. Desaturation of bile and cholesterol gallstone dissolution with chenodeoxycholic acid.
Hofmann AF
Am J Clin Nutr; 1977 Jun; 30(6):993-1000. PubMed ID: 326024
[TBL] [Abstract][Full Text] [Related]
26. Biliary lipid secretion in cholesterol gallstone disease. The effect of cholecystectomy and obesity.
Shaffer EA; Small DM
J Clin Invest; 1977 May; 59(5):828-40. PubMed ID: 856870
[TBL] [Abstract][Full Text] [Related]
27. Feasibility of low-dose and intermittent chenodeoxycholic acid therapy of gallstones.
Marks JW; Bonorris GG; Chung A; Coyne MJ; Okun R; Lachin JM; Schoenfield LJ
Am J Dig Dis; 1977 Oct; 22(10):856-60. PubMed ID: 920688
[TBL] [Abstract][Full Text] [Related]
28. Biliary lipid output during three meals and an overnight fast. I. Relationship to bile acid pool size and cholesterol saturation of bile in gallstone and control subjects.
Northfield TC; Hofmann AF
Gut; 1975 Jan; 16(1):1-11. PubMed ID: 806491
[TBL] [Abstract][Full Text] [Related]
29. Effect of chenodeoxycholic acid and phenobarbital on the rate-limiting enzymes of hepatic cholesterol and bile acid synthesis in patients with gallstones.
Coyne MJ; Bonorris GG; Goldstein LI; Schoenfield LJ
J Lab Clin Med; 1976 Feb; 87(2):281-91. PubMed ID: 1245792
[TBL] [Abstract][Full Text] [Related]
30. Effects of feeding cholic acid and chenodeoxycholic acid on cholesterol absorption and hepatic secretion of biliary lipids in man.
Einarsson K; Grundy SM
J Lipid Res; 1980 Jan; 21(1):23-34. PubMed ID: 7354252
[TBL] [Abstract][Full Text] [Related]
31. Total protein content of human gallbladder bile: relation to cholesterol gallstone disease and effects of treatment with bile acids and aspirin.
Sahlin S
Eur J Surg; 1996 Jun; 162(6):463-9. PubMed ID: 8817223
[TBL] [Abstract][Full Text] [Related]
32. Medical management of cholesterol gallstones.
Abate MA
Drug Intell Clin Pharm; 1986 Feb; 20(2):106-15. PubMed ID: 3512222
[TBL] [Abstract][Full Text] [Related]
33. Retrospective comparison of 'Cheno' and 'Urso' in the medical treatment of gallstones.
Meredith TJ; Williams GV; Maton PN; Murphy GM; Saxton HM; Dowling RH
Gut; 1982 May; 23(5):382-9. PubMed ID: 7076015
[TBL] [Abstract][Full Text] [Related]
34. Effect of chenodeoxycholic acid and ursodeoxycholic acid administration on acyl-CoA: cholesterol acyltransferase activity in human liver.
Abate N; Carubbi F; Bozzoli M; Bertolotti M; Farah I; Rosi A; Carulli N
Ital J Gastroenterol; 1994; 26(6):287-93. PubMed ID: 7949265
[TBL] [Abstract][Full Text] [Related]
35. Effects of low dose chenodeoxycholic acid feeding on biliary lipid metabolism.
Adler RD; Bennion LJ; Duane WC; Grundy SM
Gastroenterology; 1975 Feb; 68(2):326-34. PubMed ID: 1116678
[TBL] [Abstract][Full Text] [Related]
36. Effects of biliary bile acid composition on biliary cholesterol saturation in gallstone patients treated with chenodeoxycholic acid and/or ursodeoxycholic acid.
Stiehl A; Raedsch R; Czygan P; Götz R; Männer C; Walker S; Kommerell B
Gastroenterology; 1980 Dec; 79(6):1192-8. PubMed ID: 7439628
[TBL] [Abstract][Full Text] [Related]
37. Treatment of gallstones with chenodeoxycholic acid and phenobarbital.
Coyne MJ; Bonorris GG; Chung A; Goldstein LI; Lahana D; Schoenfield LJ
N Engl J Med; 1975 Mar; 292(12):604-7. PubMed ID: 1089875
[TBL] [Abstract][Full Text] [Related]
38. Effects of obesity and caloric intake on biliary lipid metabolism in man.
Bennion LJ; Grundy SM
J Clin Invest; 1975 Oct; 56(4):996-1011. PubMed ID: 1159099
[TBL] [Abstract][Full Text] [Related]
39. Pretreatment biliary lipid composition in white patients with radiolucent gallstones in the National Cooperative Gallstone Study.
Hofmann AF; Grundy SM; Lachin JM; Lan SP; Baum RA; Hanson RF; Hersh T; Hightower NC; Marks JW; Mekhjian H; Shaefer RA; Soloway RD; Thistle JL; Thomas FB; Tyor MP
Gastroenterology; 1982 Oct; 83(4):738-52. PubMed ID: 7106505
[TBL] [Abstract][Full Text] [Related]
40. [Nucleation time and growth time in patients with cholesterol gallstone--factors affecting nucleation time and growth time and effect of UDCA and CDCA].
Nomura Y
Nihon Shokakibyo Gakkai Zasshi; 1989 May; 86(5):1103-13. PubMed ID: 2795947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
